首页> 外文OA文献 >Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes.
【2h】

Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes.

机译:单核苷酸引物延伸以检测遗传疾病:血友病B(因子IX)和囊性纤维化基因的实验应用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this report, we describe an approach to detect the presence of abnormal alleles in those genetic diseases in which frequency of occurrence of the same mutation is high (e.g., cystic fibrosis and sickle cell disease), and in others in which multiple mutations cause the disease and the sequence variation in an affected member of a given family is known (e.g., hemophilia B). Initially, from each subject, the DNA fragment containing the putative mutation site is amplified by the polymerase chain reaction. For each fragment two reaction mixtures are then prepared. Each contains the amplified fragment, a primer (18-mer or longer) whose sequence is identical to the coding sequence of the normal gene immediately flanking the 5' end of the mutation site, and either an alpha-32P-labeled nucleotide corresponding to the normal coding sequence at the mutation site or an alpha-32P-labeled nucleotide corresponding to the mutant sequence. Single nucleotide primer extensions are then carried out and analyzed by denaturing polyacrylamide gel electrophoresis and autoradiography. As predicted by the Watson-Crick base-pair rule, in the wild type only the normal base, in an affected member only the mutant base, and in carriers both the normal and the mutant base are incorporated into the primer. Thus, an essential feature of the present methodology is that the base immediately 3' to the template-bound primer is one of those altered in the mutant, since in this way an extension of the primer by a single base will give an extended molecule characteristic of either the mutant or the wild type. The method is rapid and should be useful in carrier detection and prenatal diagnosis of every genetic disease with a known sequence variation.
机译:在本报告中,我们描述了一种方法,该方法可检测那些具有相同突变发生频率(例如,囊性纤维化和镰状细胞病)的遗传病高发的遗传病,以及其中多个突变引起遗传异常的那些遗传病。已知疾病和给定家庭中受影响成员的序列变异(例如,血友病B)。最初,通过聚合酶链反应从每个受试者中扩增出包含推定突变位点的DNA片段。然后为每个片段制备两种反应混合物。每个都包含扩增的片段,引物(18-mer或更长时间),其序列与突变位点5'侧翼的正常基因的编码序列相同,以及与α-32P标记的核苷酸相对应的突变位点的正常编码序列或对应于该突变序列的α-32P标记核苷酸。然后进行单核苷酸引物延伸,并通过变性聚丙烯酰胺凝胶电泳和放射自显影进行分析。如沃森-克里克碱基对法则所预测,在野生型中,仅正常碱基,在受影响的成员中,仅突变碱基,在载体中,正常碱基和突变碱基均被掺入引物中。因此,本方法的基本特征是紧靠模板结合引物3'的碱基是突变体中改变的碱基之一,因为以此方式,引物被单个碱基的延伸将提供延伸的分子特征。是突变型还是野生型。该方法是快速的,并且应该在具有已知序列变异的每种遗传疾病的载体检测和产前诊断中有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号